Healthcare -
Biotechnology - NASDAQ - US
$ 18.13
6.27 %
$ 1.44 B
Market Cap
-4.2
P/E
VRDN - OTHER LONG-TERM ASSETS
Other Long-term Assets VRDN - Viridian Therapeutics, Inc.
604 K
LAST VALUE
-36.35%
2 YEAR CAGR
64.59%
5 YEAR CAGR
-1.32%
10 YEAR CAGR